ALTUVIIIO: payments to doctors
Payments that named ALTUVIIIO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.1M
- Providers
- 865
- Transactions
- 3,243
- Average per transaction
- $949
The per-transaction average — $949 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 865 providers the average total is $3,557, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Sanofi | $2,830,058 | 92.0% |
| Sanofi US Services Inc. | $178,035 | 5.8% |
| Swedish Orphan Biovitrum AB | $52,888 | 1.7% |
| Sanofi-aventis U.S. LLC | $15,622 | 0.5% |